Jones L W, Hodes D T
Institute of Optometry, London, UK.
Ophthalmic Physiol Opt. 1991 Jan;11(1):16-21.
Cyclopentolate has been widely used as a cycloplegic and mydriatic agent for over 30 years. It has gained widespread use as the cycloplegic drug of first choice for most children over the age of 1 year and allows many optometrists and ophthalmologists to carry out quick, successful cycloplegic refractions with few complications. During this time very few side-effects have been reported with the most commonly used 1% solution. This paper outlines two cases in which a possible allergic-type reaction occurred shortly after the instillation of 1% cyclopentolate hydrochloride in 'Minims' form (Smith and Nephew). This article also reviews the uses and side-effects of cyclopentolate and aims to warn practitioners about the possibility of such reactions, ways of avoiding their occurrence and suitable measures to take should they occur.
环喷托酯作为一种睫状肌麻痹剂和散瞳剂已广泛使用30多年。它已成为大多数1岁以上儿童首选的睫状肌麻痹药物，使许多验光师和眼科医生能够快速、成功地进行睫状肌麻痹验光，且并发症很少。在此期间，使用最普遍的1%溶液报告的副作用非常少。本文概述了两例在滴入“Minims”剂型（施贵宝公司）的1%盐酸环喷托酯后不久发生疑似过敏反应的病例。本文还回顾了环喷托酯的用途和副作用，旨在提醒从业者注意此类反应的可能性、避免其发生的方法以及反应发生时应采取的适当措施。
